Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROMOSOZUMAB-AQQG for Bone density abnormal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where ROMOSOZUMAB-AQQG was used for Bone density abnormal.

Most Reported Side Effects for ROMOSOZUMAB-AQQG

Side Effect Reports % Deaths Hosp.
Fall 646 5.7% 35 360
Fracture 612 5.4% 5 135
Arthralgia 517 4.6% 0 41
Injection site pain 490 4.3% 2 15
Bone density abnormal 454 4.0% 0 1
Off label use 419 3.7% 9 73
Hospitalisation 381 3.4% 7 376
Headache 360 3.2% 1 32
Product storage error 348 3.1% 0 2
Death 263 2.3% 258 19
Spinal fracture 256 2.3% 2 52
Pain in extremity 255 2.2% 0 27
Injection site swelling 254 2.2% 0 8
Injection site erythema 247 2.2% 0 8
Pain 235 2.1% 3 32

Other Indications for ROMOSOZUMAB-AQQG

Product used for unknown indication (5,202) Osteoporosis (4,398) Osteoporosis postmenopausal (1,401) Off label use (123) Osteoporotic fracture (68) Spinal fracture (50) Senile osteoporosis (42) Osteoporosis prophylaxis (40) Osteopenia (33) Fracture (26)

Other Drugs Used for Bone density abnormal

DENOSUMAB (621) TERIPARATIDE (139) ALENDRONATE (129) ABALOPARATIDE (70) ZOLEDRONIC ACID (59) RISEDRONATE (47) IBANDRONATE (31) ALENDRONIC ACID (18) ADALIMUMAB (17) ETANERCEPT (14)

Related Pages

ROMOSOZUMAB-AQQG Full Profile All Bone density abnormal Drugs ROMOSOZUMAB-AQQG Demographics ROMOSOZUMAB-AQQG Timeline